Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
PGNY · Nasdaq · United States · Services-Misc Health & Allied Services, Nec
In shortProgyny, Inc. is profitable.
Financial health
Strong
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 6.6% | 39/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 4.5% | 38/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 12.5% | 62/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.73× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | – | n/a |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 7.14 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 14.9% | 80/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 3.28× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 22.0% | 30/100 |
| Operating margin volatility | 1.5% | 96/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 17.9% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | 29.4% | 100/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
4 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 501 | 787 | 1,089 | 1,167 | 1,289 |
| Cost of revenue | 388 | 620 | 850 | 914 | 984 |
| Gross profit | 112 | 167 | 239 | 253 | 304 |
| Research & development | – | – | – | – | 9.5 |
| Operating income | 32 | 23 | 62 | 67 | 85 |
| Pre-tax income | 32 | 24 | 71 | 83 | 95 |
| Income tax | (33) | (5.9) | 8.7 | 29 | 37 |
| Net income | 66 | 30 | 62 | 54 | 59 |
| Diluted EPS | $0.66 | $0.30 | $0.62 | $0.57 | $0.65 |
| Diluted shares (millions) | 100 | 100 | 101 | 95 | 90 |
4 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of Progyny, Inc. are included in the Investor plan. Try free for 7 days →
7.14 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 7, 2026